{"recordsFiltered":48671,"recordsTotal":48671,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=sponsor__name&start=40500","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=sponsor__name&start=39900","results":[{"registry_id":"NCT05546996","publication_url":"https://clinicaltrials.gov/study/NCT05546996","title":"The Correlation Between FlowSense Flow Rate Measurements and: EVD Drainage Data and Intracranial Pressure (ICP) Measurements","has_exemption":false,"start_date":"2023-07-11","completion_date":"2027-01-30","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06035497","publication_url":"https://clinicaltrials.gov/study/NCT06035497","title":"A Phase 1/2 Study of the Safety, Tolerability, Pharmacokinetics, and Efficacy of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)","has_exemption":false,"start_date":"2023-11-20","completion_date":"2027-01-30","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06444256","publication_url":"https://clinicaltrials.gov/study/NCT06444256","title":"Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder: A Pilot Study","has_exemption":false,"start_date":"2024-07-25","completion_date":"2027-01-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06410313","publication_url":"https://clinicaltrials.gov/study/NCT06410313","title":"First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease","has_exemption":false,"start_date":"2024-08-15","completion_date":"2027-01-30","has_results":false,"results_due":false,"sponsor_name":"Medinol Ltd.","sponsor_slug":"medinol-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06589986","publication_url":"https://clinicaltrials.gov/study/NCT06589986","title":"A Phase III, Multicenter, Double-Blind, Placebo-Controlled, Treat-Through Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With RO7790121 in Patients With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2024-09-17","completion_date":"2027-01-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06638398","publication_url":"https://clinicaltrials.gov/study/NCT06638398","title":"Assessing a Biomarker Platform for Stratifying Indeterminate Pulmonary Nodules - The SPOT IT Platform Trial","has_exemption":false,"start_date":"2024-10-31","completion_date":"2027-01-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt-Ingram Cancer Center","sponsor_slug":"vanderbilt-ingram-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06588855","publication_url":"https://clinicaltrials.gov/study/NCT06588855","title":"A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Patients With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2024-12-11","completion_date":"2027-01-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07145515","publication_url":"https://clinicaltrials.gov/study/NCT07145515","title":"Enhancing Heart Allograft Function With the OCS Heart System (ENHANCE) Trial","has_exemption":false,"start_date":"2026-01-31","completion_date":"2027-01-30","has_results":false,"results_due":false,"sponsor_name":"TransMedics","sponsor_slug":"transmedics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06860815","publication_url":"https://clinicaltrials.gov/study/NCT06860815","title":"Pilot Study of Cemiplimab and Hepatic Radioembolization in Patients With Liver Dominant Metastatic Breast Cancer","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-01-30","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07538570","publication_url":"https://clinicaltrials.gov/study/NCT07538570","title":"A Phase 4, Double-blind, Sequential Cohort Study of Pain Treatment and Recovery After Total Knee Arthroplasty","has_exemption":false,"start_date":"2026-04-22","completion_date":"2027-01-30","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01345851","publication_url":"https://clinicaltrials.gov/study/NCT01345851","title":"Image-Guided Hypofractionated Radiotherapy With Stereotactic Boost and Chemotherapy for Inoperable Stage II-III Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2011-03-23","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01474148","publication_url":"https://clinicaltrials.gov/study/NCT01474148","title":"A Neuroprosthesis for Seated Posture and Balance","has_exemption":false,"start_date":"2011-11-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01979367","publication_url":"https://clinicaltrials.gov/study/NCT01979367","title":"To Evaluate the Efficacy Treatment of Lower Extremity Pathologies Derived From Neurological Ischemia Disorders","has_exemption":false,"start_date":"2012-03-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"American Association of Sensory Electrodiagnostic Medicine","sponsor_slug":"american-association-of-sensory-electrodiagnostic-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01915810","publication_url":"https://clinicaltrials.gov/study/NCT01915810","title":"Using Physical Activity to Facilitate Smoking Cessation Among African American Adults","has_exemption":false,"start_date":"2014-01-29","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02048332","publication_url":"https://clinicaltrials.gov/study/NCT02048332","title":"Donor-Derived Viral Specific T-cells (VSTs) for Treatment of Viral Infections After Allogeneic Stem Cell Transplant","has_exemption":false,"start_date":"2014-02-05","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02473536","publication_url":"https://clinicaltrials.gov/study/NCT02473536","title":"Safety Lead-in Phase II Trial of Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCC","has_exemption":false,"start_date":"2015-06-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02658279","publication_url":"https://clinicaltrials.gov/study/NCT02658279","title":"A Proof-of-Concept, Pilot Study of Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype","has_exemption":false,"start_date":"2016-01-22","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02670707","publication_url":"https://clinicaltrials.gov/study/NCT02670707","title":"Randomization of Cytarabine Monotherapy Versus Standard-of-Care Vinblastine/Prednisone for Frontline Treatment of Langerhans Cell Histiocytosis (TXCH LCH0115)","has_exemption":false,"start_date":"2016-03-07","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02713607","publication_url":"https://clinicaltrials.gov/study/NCT02713607","title":"Lipidome and Microbiome Profile of Acne","has_exemption":false,"start_date":"2016-03-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03663543","publication_url":"https://clinicaltrials.gov/study/NCT03663543","title":"The Use of Peri-Operative Intravenous Estrogen for the Mitigation of Ischemia Reperfusion Injury in the Setting of Renal Transplantation","has_exemption":false,"start_date":"2016-08-26","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02964884","publication_url":"https://clinicaltrials.gov/study/NCT02964884","title":"Neurobiology and Treatment of Reading Disability in NF1","has_exemption":false,"start_date":"2016-11-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University","sponsor_slug":"vanderbilt-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02476786","publication_url":"https://clinicaltrials.gov/study/NCT02476786","title":"Endocrine Treatment Alone as Primary Treatment for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score","has_exemption":false,"start_date":"2017-01-17","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03033914","publication_url":"https://clinicaltrials.gov/study/NCT03033914","title":"Phase I/II of Nivolumab and A(B)VD in the Front-line Setting for High Risk Hodgkin Lymphoma","has_exemption":false,"start_date":"2017-01-25","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03104439","publication_url":"https://clinicaltrials.gov/study/NCT03104439","title":"Nivolumab and Ipilimumab and Radiation Therapy in Microsatellite Stable (MSS) and Microsatellite Instability (MSI) High Colorectal and Pancreatic Cancer","has_exemption":false,"start_date":"2017-05-10","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02989025","publication_url":"https://clinicaltrials.gov/study/NCT02989025","title":"Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia-The PROGRESS Pilot Study","has_exemption":false,"start_date":"2017-05-22","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Mississippi Medical Center","sponsor_slug":"university-of-mississippi-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03153319","publication_url":"https://clinicaltrials.gov/study/NCT03153319","title":"Phase 1/2 Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I, II, and VI","has_exemption":false,"start_date":"2017-06-05","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","sponsor_slug":"lundquist-institute-for-biomedical-innovation-at-harbor-ucla-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03026816","publication_url":"https://clinicaltrials.gov/study/NCT03026816","title":"Epidural Stimulation for Spinal Cord Injury","has_exemption":false,"start_date":"2017-08-07","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03267433","publication_url":"https://clinicaltrials.gov/study/NCT03267433","title":"A Randomized Phase III Trial of Consolidation With Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs Maintenance Rituximab Alone for Patients With Mantle Cell Lymphoma in Minimal Residual Disease-Negative First Complete Remission","has_exemption":false,"start_date":"2017-11-27","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"ECOG-ACRIN Cancer Research Group","sponsor_slug":"ecog-acrin-cancer-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03087071","publication_url":"https://clinicaltrials.gov/study/NCT03087071","title":"A Phase II Enrichment Study of Panitumumab as a Single Agent or in Combination With Trametinib in Anti-EGFR-Refractory Stage IV Colorectal Cancer Patients","has_exemption":false,"start_date":"2017-12-29","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03325322","publication_url":"https://clinicaltrials.gov/study/NCT03325322","title":"Frailty, Inflammation, and Stem Cell Functionality in Chronic Kidney Disease","has_exemption":false,"start_date":"2018-01-02","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03420508","publication_url":"https://clinicaltrials.gov/study/NCT03420508","title":"A Phase 2 Study of the ALK Inhibitor Ensartinib for Patients With Melanomas Harboring ALK Alterations or Aberrant ALK Expression","has_exemption":false,"start_date":"2018-01-10","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03410875","publication_url":"https://clinicaltrials.gov/study/NCT03410875","title":"A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia","has_exemption":false,"start_date":"2018-02-09","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03520491","publication_url":"https://clinicaltrials.gov/study/NCT03520491","title":"A Pilot Study to Evaluate the Safety of Neoadjuvant Nivolumab Alone or in Combination With Ipilimumab for Cisplatin-Ineligible Patients With Muscle Invasive Bladder Cancer (CA209-9DJ)","has_exemption":false,"start_date":"2018-04-25","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03465592","publication_url":"https://clinicaltrials.gov/study/NCT03465592","title":"Single-arm, Open-label, Phase 1b/2 Trial of Nivolumab Therapy Following Partially HLA Mismatched (Haploidentical) Bone Marrow Transplant in Children and Young Adults With High Risk, Recurrent or Refractory Sarcomas","has_exemption":false,"start_date":"2018-05-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03295981","publication_url":"https://clinicaltrials.gov/study/NCT03295981","title":"Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone: A Prospective Randomized Controlled Trial","has_exemption":false,"start_date":"2018-05-03","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"St. Louis University","sponsor_slug":"st-louis-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03587662","publication_url":"https://clinicaltrials.gov/study/NCT03587662","title":"Phase II Trial of Ixazomib Combined With Gemcitabine and Doxorubicin in Patients With Renal Medullary Carcinoma","has_exemption":false,"start_date":"2018-08-17","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03808337","publication_url":"https://clinicaltrials.gov/study/NCT03808337","title":"PROMISE-005: A Phase II Randomized Study Assessing the Efficacy of Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Breast or Lung Cancer","has_exemption":false,"start_date":"2019-01-16","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03808662","publication_url":"https://clinicaltrials.gov/study/NCT03808662","title":"Precision Radiation for OligoMetastatIc and MetaStatic DiseasE (PROMISE)-004: Consolidative Use of Radiotherapy to Block (CURB) Oligoprogression","has_exemption":false,"start_date":"2019-01-16","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03839498","publication_url":"https://clinicaltrials.gov/study/NCT03839498","title":"Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma","has_exemption":false,"start_date":"2019-01-22","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03684109","publication_url":"https://clinicaltrials.gov/study/NCT03684109","title":"Pilot Study for Non-invasive Glioma Characterization Through Molecular Imaging","has_exemption":false,"start_date":"2019-01-25","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03793465","publication_url":"https://clinicaltrials.gov/study/NCT03793465","title":"Pilot-Tart Cherry, Mitral Transcriptome and POAF Incidence","has_exemption":false,"start_date":"2019-02-08","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03836261","publication_url":"https://clinicaltrials.gov/study/NCT03836261","title":"A Randomized, Multicenter, Open-Label, Phase 3 Study to Compare the Efficacy and Safety of Acalabrutinib (ACP-196) in Combination With Venetoclax With and Without Obinutuzumab Compared to Investigator's Choice of Chemoimmunotherapy in Subjects With Previously Untreated Chronic Lymphocytic Leukemia Without Del(17p) or TP53 Mutation (AMPLIFY)","has_exemption":false,"start_date":"2019-02-25","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Acerta Pharma BV","sponsor_slug":"acerta-pharma-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03862157","publication_url":"https://clinicaltrials.gov/study/NCT03862157","title":"A Phase I/II Study of Azacitidine, Venetoclax and Pevonedistat in Adults With Newly Diagnosed Secondary or Therapy-Related AML","has_exemption":false,"start_date":"2019-02-27","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03744793","publication_url":"https://clinicaltrials.gov/study/NCT03744793","title":"A Phase II Trial to Evaluate Combination Therapy With Pemetrexed and Avelumab in Previously Treated Patients With MTAP-Deficient Advanced Urothelial Cancer","has_exemption":false,"start_date":"2019-04-11","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03971409","publication_url":"https://clinicaltrials.gov/study/NCT03971409","title":"Innovative Combination Immunotherapy for Metastatic Triple Negative Breast Cancer (TNBC): A Multicenter, Multi-Arm Translational Breast Cancer Research Consortium Study","has_exemption":false,"start_date":"2019-07-08","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Laura Huppert, MD, BA","sponsor_slug":"laura-huppert-md-ba","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03815656","publication_url":"https://clinicaltrials.gov/study/NCT03815656","title":"An Integrated Biomarker Approach to Personalized, Adaptive Deep Brain Stimulation in Parkinson Disease [Formerly: Scalar Closed-Loop STN/GPi DBS Based on Evoked and Spontaneous Potentials (Permanently Implanted Medtronic RC+S Studies)]","has_exemption":false,"start_date":"2019-07-10","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Dennis Turner, M.D.","sponsor_slug":"dennis-turner-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04099823","publication_url":"https://clinicaltrials.gov/study/NCT04099823","title":"MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics and Association of Intracranial CSF Flow With Brain Function","has_exemption":false,"start_date":"2019-10-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04152551","publication_url":"https://clinicaltrials.gov/study/NCT04152551","title":"Effects of Bisphosphonates on OI-Related Hearing Loss: A Pilot Study","has_exemption":false,"start_date":"2019-11-02","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04178018","publication_url":"https://clinicaltrials.gov/study/NCT04178018","title":"Transvaginal Ultrasound and Photoacoustic Imaging of the Ovary","has_exemption":false,"start_date":"2020-02-09","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04253262","publication_url":"https://clinicaltrials.gov/study/NCT04253262","title":"A Phase Ib/II Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer","has_exemption":false,"start_date":"2020-04-03","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Brown University","sponsor_slug":"brown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04033081","publication_url":"https://clinicaltrials.gov/study/NCT04033081","title":"Registry of Retroperitoneal, Abdominal, Pelvic and Truncal Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet® to Evaluate the Safety and Feasibility Over 5 Years","has_exemption":false,"start_date":"2020-04-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"CivaTech Oncology","sponsor_slug":"civatech-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04241185","publication_url":"https://clinicaltrials.gov/study/NCT04241185","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Participants With Muscle-invasive Bladder Cancer (MIBC) (KEYNOTE-992)","has_exemption":false,"start_date":"2020-05-19","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04248205","publication_url":"https://clinicaltrials.gov/study/NCT04248205","title":"Intra-operative Use of Ketamine for Post-Operative Analgesia in Patients Undergoing Hemorrhoidectomy: A Prospective, Randomized Controlled Trial.","has_exemption":false,"start_date":"2020-06-15","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04267848","publication_url":"https://clinicaltrials.gov/study/NCT04267848","title":"Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)","has_exemption":false,"start_date":"2020-06-16","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04195347","publication_url":"https://clinicaltrials.gov/study/NCT04195347","title":"CRSPA: Phase I/II Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase","has_exemption":false,"start_date":"2020-09-04","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04304768","publication_url":"https://clinicaltrials.gov/study/NCT04304768","title":"Immune Dysfunction in HIV+ Opioid Users","has_exemption":false,"start_date":"2020-11-18","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04666740","publication_url":"https://clinicaltrials.gov/study/NCT04666740","title":"A Phase 2 Trial to Evaluate the Safety and Antitumor Activity of Pembrolizumab and OLApaRib (POLAR) Maintenance for Patients With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency and/or Exceptional Treatment Response to Platinum-Based Therapy","has_exemption":false,"start_date":"2020-12-18","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04662255","publication_url":"https://clinicaltrials.gov/study/NCT04662255","title":"A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator Choice of BTK Inhibitor in Patients With Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN MCL-321)","has_exemption":false,"start_date":"2021-04-08","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Loxo Oncology, Inc.","sponsor_slug":"loxo-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04270175","publication_url":"https://clinicaltrials.gov/study/NCT04270175","title":"Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab","has_exemption":false,"start_date":"2021-04-14","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04683679","publication_url":"https://clinicaltrials.gov/study/NCT04683679","title":"Phase II Study of Pembrolizumab and Ablative Radiotherapy With or Without Olaparib in Metastatic Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancers : Initial Test Cohorts of a Platform Trial to Sequentially Investigate Immunotherapy Combinations for the Augmentation of Immune Responses","has_exemption":false,"start_date":"2021-04-21","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04547257","publication_url":"https://clinicaltrials.gov/study/NCT04547257","title":"Safety and Effectiveness Evaluation of Seraph 100 Microbind Affinity Blood Filter (Seraph 100) in the Treatment of Patients With COVID-19","has_exemption":false,"start_date":"2021-05-04","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"ExThera Medical Corporation","sponsor_slug":"exthera-medical-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04891510","publication_url":"https://clinicaltrials.gov/study/NCT04891510","title":"A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery","has_exemption":false,"start_date":"2021-05-19","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04876456","publication_url":"https://clinicaltrials.gov/study/NCT04876456","title":"A Phase II Trial Evaluating the Efficacy of Cabozantinib in the Treatment of Incurable Patients With Refractory Germ Cell Tumors","has_exemption":false,"start_date":"2021-06-10","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Jennifer King","sponsor_slug":"jennifer-king","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04712851","publication_url":"https://clinicaltrials.gov/study/NCT04712851","title":"A Phase II Open-Label, Single Arm Pilot Study to Evaluate the Safety and Efficacy of Pembrolizumab for High-Grade Cervical Intraepithelial Neoplasia","has_exemption":false,"start_date":"2021-06-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04780204","publication_url":"https://clinicaltrials.gov/study/NCT04780204","title":"A Multicenter, Open-label, Single Arm Trial for the Effectiveness of Antiviral Treatment in Cirrhotic Patients with Low-level Hepatitis B Virus DNA Levels with a Comparison to Matched Historical Controls (ATTACH)","has_exemption":false,"start_date":"2021-08-23","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Asan Medical Center","sponsor_slug":"asan-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03694158","publication_url":"https://clinicaltrials.gov/study/NCT03694158","title":"Effect of IL-4RαR576 Polymorphism on Response to Dupilumab in Asthma, a Genotype-stratified, Randomized, Placebo- Controlled Trial","has_exemption":false,"start_date":"2021-09-08","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04728633","publication_url":"https://clinicaltrials.gov/study/NCT04728633","title":"Chemoembolization of Uveal Melanoma Hepatic Metastases Using 300mg of BCNU Dissolved in Lipiodol® Followed by Gelfoam® Embolization","has_exemption":false,"start_date":"2021-09-27","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04446585","publication_url":"https://clinicaltrials.gov/study/NCT04446585","title":"A Cluster Randomized Clinical Trial of Strategic AED Deployment in High-risk Residential Areas Combined With Activation of Local Residents","has_exemption":false,"start_date":"2021-12-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Emergency Medical Services, Capital Region, Denmark","sponsor_slug":"emergency-medical-services-capital-region-denmark","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04847466","publication_url":"https://clinicaltrials.gov/study/NCT04847466","title":"A Phase II Study of Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer","has_exemption":false,"start_date":"2021-12-14","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05188508","publication_url":"https://clinicaltrials.gov/study/NCT05188508","title":"A Phase II Study of Pembrolizumab, Olaparib, and Temozolomide in Patients With Glioma","has_exemption":false,"start_date":"2022-01-14","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04743505","publication_url":"https://clinicaltrials.gov/study/NCT04743505","title":"Phase I/II Study Exploring the Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2022-01-18","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05203445","publication_url":"https://clinicaltrials.gov/study/NCT05203445","title":"Phase II of Neoadjuvant Olaparib in Combination With Pembrolizumab in Patients With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer and Germline Mutations in DNA Damage Repair Genes","has_exemption":false,"start_date":"2022-01-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05204888","publication_url":"https://clinicaltrials.gov/study/NCT05204888","title":"myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home - a Multi-center Randomized Controlled Trial","has_exemption":false,"start_date":"2022-02-02","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Temple University","sponsor_slug":"temple-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05027906","publication_url":"https://clinicaltrials.gov/study/NCT05027906","title":"A Phase 1b, Multicenter, Open Label Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant","has_exemption":false,"start_date":"2022-02-18","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Eledon Pharmaceuticals","sponsor_slug":"eledon-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04771416","publication_url":"https://clinicaltrials.gov/study/NCT04771416","title":"A Phase 1/2 Open-Label, Multicenter Dose-Ranging and Confirmatory Study to Assess the Safety, Tolerability and Efficacy of PBKR03 Administered to Pediatric Subjects With Early Infantile Krabbe Disease (Globoid Cell Leukodystrophy)","has_exemption":false,"start_date":"2022-02-24","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Gemma Biotherapeutics","sponsor_slug":"gemma-biotherapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05160506","publication_url":"https://clinicaltrials.gov/study/NCT05160506","title":"Corticosteroids to Reduce Inflammation in Severe Pancreatitis: A Randomized, Controlled Study","has_exemption":false,"start_date":"2022-03-06","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03936478","publication_url":"https://clinicaltrials.gov/study/NCT03936478","title":"A Phase II Study of Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer (MAPBI)","has_exemption":false,"start_date":"2022-05-16","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05329766","publication_url":"https://clinicaltrials.gov/study/NCT05329766","title":"A Phase 2 Trial to Evaluate the Safety and Efficacy of Combination Therapies in Patients With Advanced Upper Gastrointestinal Tract Malignancies (EDGE-Gastric)","has_exemption":false,"start_date":"2022-06-10","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Arcus Biosciences, Inc.","sponsor_slug":"arcus-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05406713","publication_url":"https://clinicaltrials.gov/study/NCT05406713","title":"Neoadjuvant Pembrolizumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing","has_exemption":false,"start_date":"2022-07-13","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Matthew Galsky","sponsor_slug":"matthew-galsky","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05406362","publication_url":"https://clinicaltrials.gov/study/NCT05406362","title":"A Randomised, Placebo Controlled, Double Blind, Multicentre Proof of Concept Study to Assess the Safety and Efficacy of Two Doses of VAD044 in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)","has_exemption":false,"start_date":"2022-07-18","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Vaderis Therapeutics AG","sponsor_slug":"vaderis-therapeutics-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05047172","publication_url":"https://clinicaltrials.gov/study/NCT05047172","title":"Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)","has_exemption":false,"start_date":"2022-08-02","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05444361","publication_url":"https://clinicaltrials.gov/study/NCT05444361","title":"Eliminating Post-Mastectomy Pain and Opioids With Percutaneous Cryoneurolysis: A Single-Administration, Non-Opioid, Non-Addictive, Multiple-Month Analgesic","has_exemption":false,"start_date":"2022-09-15","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05358535","publication_url":"https://clinicaltrials.gov/study/NCT05358535","title":"Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)","has_exemption":false,"start_date":"2022-09-19","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05598398","publication_url":"https://clinicaltrials.gov/study/NCT05598398","title":"Evaluation of Vacuum-Assisted Closure Veraflo Therapy With Cleanse Choice Dressing on Wound Healing in Patients With Pressure Sores: A Prospective, Randomized Controlled Trial","has_exemption":false,"start_date":"2022-09-26","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05491525","publication_url":"https://clinicaltrials.gov/study/NCT05491525","title":"A Phase 2/3, Open-label, Baseline-controlled, Multicenter, Long-term Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With Neurogenic Detrusor Overactivity (NDO) on Clean Intermittent Catheterization (CIC)","has_exemption":false,"start_date":"2022-10-12","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Urovant Sciences GmbH","sponsor_slug":"urovant-sciences-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05540860","publication_url":"https://clinicaltrials.gov/study/NCT05540860","title":"A 2-part Phase 2 Study of Safety, Pharmacokinetics and Biomarkers in Children With Duchenne Muscular Dystrophy Including a Randomized, Double-Blind, Placebo-Controlled Part A, Followed by an Open-Label Part B","has_exemption":false,"start_date":"2022-10-24","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Edgewise Therapeutics, Inc.","sponsor_slug":"edgewise-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05567848","publication_url":"https://clinicaltrials.gov/study/NCT05567848","title":"Accelerated Transcranial Magnetic Stimulation in Psychotic Disorders","has_exemption":false,"start_date":"2022-11-29","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05419479","publication_url":"https://clinicaltrials.gov/study/NCT05419479","title":"Phase Ib Open-Label, Multicenter, Study Evaluating the Safety and Efficacy of 'Switch Maintenance' Combination Immunotherapy Using AB154, AB122, and Sotigalimab in Patients With Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2022-11-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"James Cleary, MD, PhD","sponsor_slug":"james-cleary-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05741242","publication_url":"https://clinicaltrials.gov/study/NCT05741242","title":"A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors","has_exemption":false,"start_date":"2022-11-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Jaime Leandro Foundation for Therapeutic Cancer Vaccines","sponsor_slug":"jaime-leandro-foundation-for-therapeutic-cancer-vaccines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05586776","publication_url":"https://clinicaltrials.gov/study/NCT05586776","title":"Decolonization to Reduce After-Surgery Events of Surgical Site Infection","has_exemption":false,"start_date":"2023-01-17","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05256641","publication_url":"https://clinicaltrials.gov/study/NCT05256641","title":"Acalabrutinib Maintenance Following Cellular Therapy for Large B-Cell Lymphoma Patients at Very High Risk for Relapse","has_exemption":false,"start_date":"2023-01-23","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05732272","publication_url":"https://clinicaltrials.gov/study/NCT05732272","title":"Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment","has_exemption":false,"start_date":"2023-02-28","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05644041","publication_url":"https://clinicaltrials.gov/study/NCT05644041","title":"Phase II Trial of Intravesical Gemcitabine + Docetaxel in Patients With Nonmuscle Invasive Bladder Cancer With or Without Prior Bacillus Calmette-Guérin Therapy","has_exemption":false,"start_date":"2023-03-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669534","publication_url":"https://clinicaltrials.gov/study/NCT05669534","title":"Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP","has_exemption":false,"start_date":"2023-03-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Connecticut","sponsor_slug":"university-of-connecticut","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05511909","publication_url":"https://clinicaltrials.gov/study/NCT05511909","title":"Evaluating a Mechanistically-Supported Pharmacotherapy to Treat Opioid Withdrawal","has_exemption":false,"start_date":"2023-03-15","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05538897","publication_url":"https://clinicaltrials.gov/study/NCT05538897","title":"A Phase IB and Randomized Phase II Trial of Megestrol Acetate With or Without Ipatasertib in Recurrent or Metastatic Endometrioid Endometrial Cancer","has_exemption":false,"start_date":"2023-03-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05626712","publication_url":"https://clinicaltrials.gov/study/NCT05626712","title":"Clinical Trial to Evaluate the Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes (CREATE-1)","has_exemption":false,"start_date":"2023-04-07","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Creative Medical Technology Holdings Inc","sponsor_slug":"creative-medical-technology-holdings-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05755113","publication_url":"https://clinicaltrials.gov/study/NCT05755113","title":"A Phase IIa Open Label Study Evaluating the Preliminary Efficacy of Intratumoural Tigilanol Tiglate in Advanced and/or Metastatic Soft Tissue Sarcoma of the Extremities and Body Wall.","has_exemption":false,"start_date":"2023-04-13","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"QBiotics Group Limited","sponsor_slug":"qbiotics-group-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04796012","publication_url":"https://clinicaltrials.gov/study/NCT04796012","title":"VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors: An Open-label, Phase II, Single-arm, Multi-center Trial","has_exemption":false,"start_date":"2023-04-18","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05560477","publication_url":"https://clinicaltrials.gov/study/NCT05560477","title":"A Prospective, Randomized, Controlled, Double-Blinded, Multi-Center, Phase 1/2b Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing","has_exemption":false,"start_date":"2023-04-26","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05704036","publication_url":"https://clinicaltrials.gov/study/NCT05704036","title":"Estrogen Supplementation and Bone Health in Women With CF (STURDY)","has_exemption":false,"start_date":"2023-05-02","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05580601","publication_url":"https://clinicaltrials.gov/study/NCT05580601","title":"Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)","has_exemption":false,"start_date":"2023-05-05","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05908734","publication_url":"https://clinicaltrials.gov/study/NCT05908734","title":"A Phase 1/2 Study Evaluating the Safety and Efficacy of Amivantamab and Cetrelimab Combination Therapy in Metastatic Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2023-05-18","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05845671","publication_url":"https://clinicaltrials.gov/study/NCT05845671","title":"A Phase 1 / 2, Open Label, Study of Amivantamab (JNJ-61186372) Among Participants With Advanced NSCLC Harboring ALK, ROS1, and RET Gene Fusions in Combination With Tyrosine Kinase Inhibitors","has_exemption":false,"start_date":"2023-07-17","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05677100","publication_url":"https://clinicaltrials.gov/study/NCT05677100","title":"DRAIN-HF: Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure","has_exemption":false,"start_date":"2023-08-23","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Procyrion","sponsor_slug":"procyrion","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05761951","publication_url":"https://clinicaltrials.gov/study/NCT05761951","title":"Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer","has_exemption":false,"start_date":"2023-08-29","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05675865","publication_url":"https://clinicaltrials.gov/study/NCT05675865","title":"Cryoablation for Monomorphic Ventricular Tachycardia IDE Study: EFS and Pivotal","has_exemption":false,"start_date":"2023-09-11","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Adagio Medical","sponsor_slug":"adagio-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06034327","publication_url":"https://clinicaltrials.gov/study/NCT06034327","title":"Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens","has_exemption":false,"start_date":"2023-09-18","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"SightGlass Vision, Inc.","sponsor_slug":"sightglass-vision-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05941507","publication_url":"https://clinicaltrials.gov/study/NCT05941507","title":"A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of TROP2-Directed Antibody-Drug Conjugate LCB84, as a Single Agent and in Combination With an Anti-PD-1 Ab, in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2023-10-05","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"LigaChem Biosciences, Inc.","sponsor_slug":"ligachem-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06056895","publication_url":"https://clinicaltrials.gov/study/NCT06056895","title":"A Proof-of-Concept Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma","has_exemption":false,"start_date":"2023-11-08","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06075771","publication_url":"https://clinicaltrials.gov/study/NCT06075771","title":"Dopaminergic Therapy for Inflammation-Related Anhedonia in Depression - 2","has_exemption":false,"start_date":"2023-11-21","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06029972","publication_url":"https://clinicaltrials.gov/study/NCT06029972","title":"A Phase 2, Double-Blinded, Randomized, Placebo-Controlled, Dose-Ranging Study Evaluating the Efficacy and Safety of GS-5290 in Participants With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2023-12-05","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05534646","publication_url":"https://clinicaltrials.gov/study/NCT05534646","title":"Phase II Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2023-12-27","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Edwin Posadas, MD","sponsor_slug":"edwin-posadas-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06178952","publication_url":"https://clinicaltrials.gov/study/NCT06178952","title":"Transcranial Pulse Stimulation (TPS) in Post-COVID-19","has_exemption":false,"start_date":"2024-01-08","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of Vienna","sponsor_slug":"medical-university-of-vienna","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05852158","publication_url":"https://clinicaltrials.gov/study/NCT05852158","title":"The Use of Single Dose vs Short-Term Peri-Operative Cefazolin in the Prevention of Surgical Site Infection Following Orthognathic Surgery","has_exemption":false,"start_date":"2024-01-09","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Abdul El-Rabbany","sponsor_slug":"abdul-el-rabbany","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06808035","publication_url":"https://clinicaltrials.gov/study/NCT06808035","title":"Understanding Perinatal Spinal Cord Injury: Comprehensive Assessment and Personalized Neuromodulation for Improved Whole-Body Functions","has_exemption":false,"start_date":"2024-01-09","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05723601","publication_url":"https://clinicaltrials.gov/study/NCT05723601","title":"Addressing Preference as a Patient-centered Outcome to Prevent Recurrent Urinary Tract Infection (rUTI) in Post-menopausal Women: a Cross-over Randomized Controlled Trial","has_exemption":false,"start_date":"2024-01-12","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06447025","publication_url":"https://clinicaltrials.gov/study/NCT06447025","title":"An Open-Label Extension Study to Assess the Long-Term Safety, Efficacy, Pharmacodynamics, Pharmacokinetics, and Tolerability of Subcutaneous CTI-1601 in Subjects With Friedreich's Ataxia","has_exemption":false,"start_date":"2024-01-25","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Larimar Therapeutics, Inc.","sponsor_slug":"larimar-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05571059","publication_url":"https://clinicaltrials.gov/study/NCT05571059","title":"A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Determine the Safety and Efficacy of Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)","has_exemption":false,"start_date":"2024-01-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Cumberland Pharmaceuticals","sponsor_slug":"cumberland-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05827055","publication_url":"https://clinicaltrials.gov/study/NCT05827055","title":"Role of Cholecystokinin Receptor Blockade on the Tumor Microenvironment in Pancreatic Cancer","has_exemption":false,"start_date":"2024-01-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05900570","publication_url":"https://clinicaltrials.gov/study/NCT05900570","title":"The Effect of Acute Peri-Urethral Neurostimulation on Intra-Urethral Pressure In Women With Stress Urinary Incontinence (SUI) - Urodynamic Early Feasibility Study","has_exemption":false,"start_date":"2024-02-26","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Corewell Health East","sponsor_slug":"corewell-health-east","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06233877","publication_url":"https://clinicaltrials.gov/study/NCT06233877","title":"An Open Label Phase 2 Trial to Evaluate the Safety, Tolerability, and Efficacy of Low Dose G-FLIP in Combination With Mitomycin C in Patients With Stage IV Pancreatic Cancer Who Have Failed First-Line Treatment","has_exemption":false,"start_date":"2024-03-15","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Hirschfeld Oncology","sponsor_slug":"hirschfeld-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05766670","publication_url":"https://clinicaltrials.gov/study/NCT05766670","title":"Intramedullary Calcium Sulfate Antibiotic Depot for Prevention of Open Fracture Related Infection: A Randomized Clinical Trial","has_exemption":false,"start_date":"2024-04-08","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06431893","publication_url":"https://clinicaltrials.gov/study/NCT06431893","title":"An Open-Label, Phase 3 Long-Term Extension (LTE) Study To Assess The Safety, Tolerability, And Efficacy Of Treatment With Pegtibatinase In Participants With Classical Homocystinuria (HCU) Due To Cystathionine Beta Synthase Deficiency (ENSEMBLE)","has_exemption":false,"start_date":"2024-04-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Travere Therapeutics, Inc.","sponsor_slug":"travere-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06213311","publication_url":"https://clinicaltrials.gov/study/NCT06213311","title":"A Phase 2 Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma","has_exemption":false,"start_date":"2024-05-07","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06273904","publication_url":"https://clinicaltrials.gov/study/NCT06273904","title":"Modulating Escape in the Anxiety Disorder Spectrum: Targeting the Direct Neural Mediator Using Transcranial Focused Ultrasound","has_exemption":false,"start_date":"2024-05-20","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05804370","publication_url":"https://clinicaltrials.gov/study/NCT05804370","title":"A Phase 3 Multicenter Study of Gleolan™ (Aminolevulinic Acid Hydrochloride) to Enhance Visualization of Tumor in Patients With Suspected Newly Diagnosed or Recurrent Epithelial Ovarian Cancer","has_exemption":false,"start_date":"2024-05-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"NX Development Corp","sponsor_slug":"nx-development-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06191965","publication_url":"https://clinicaltrials.gov/study/NCT06191965","title":"Double Blind, Randomized, Placebo-Controlled Study of MitoQ as Adjunctive Treatment for Patients With Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction","has_exemption":false,"start_date":"2024-06-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Mclean Hospital","sponsor_slug":"mclean-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05814055","publication_url":"https://clinicaltrials.gov/study/NCT05814055","title":"The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence","has_exemption":false,"start_date":"2024-06-06","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06252532","publication_url":"https://clinicaltrials.gov/study/NCT06252532","title":"Modulating Oscillations and Working Memory in Patients With Subdural Electrodes","has_exemption":false,"start_date":"2024-07-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06384261","publication_url":"https://clinicaltrials.gov/study/NCT06384261","title":"Multicenter, Open-label, Randomized, Phase 2 Study of Venetoclax and Azacitidine Plus Cusatuzumab Versus Venetoclax and Azacitidine Alone in Newly Diagnosed AML Patients Who Are Not Candidates for Intensive Therapy","has_exemption":false,"start_date":"2024-07-22","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"OncoVerity, Inc.","sponsor_slug":"oncoverity-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05896839","publication_url":"https://clinicaltrials.gov/study/NCT05896839","title":"A Phase 2 Study of Nivolumab and Ipilimumab in Combination With Sirolimus and Prednisone in Kidney Transplant Recipients With Selected Unresectable or Metastatic Cutaneous Cancers","has_exemption":false,"start_date":"2024-07-24","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06386146","publication_url":"https://clinicaltrials.gov/study/NCT06386146","title":"A Phase 1/2a, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Evidence of Antitumor Activity of JAB-30355 in Adult Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation","has_exemption":false,"start_date":"2024-07-24","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Jacobio Pharmaceuticals Co., Ltd.","sponsor_slug":"jacobio-pharmaceuticals-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05895513","publication_url":"https://clinicaltrials.gov/study/NCT05895513","title":"Effect of Pimavanserin on Aggression and Social Cognition.","has_exemption":false,"start_date":"2024-08-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05997693","publication_url":"https://clinicaltrials.gov/study/NCT05997693","title":"One Month Dual Antiplatelet Therapy With Ticagrelor in Coronary Artery Bypass Graft Patients","has_exemption":false,"start_date":"2024-08-15","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06443970","publication_url":"https://clinicaltrials.gov/study/NCT06443970","title":"Physiological Consequences of Low and High Flow Endotracheal Suctioning Devices in Intubated Preterm and Term Infants","has_exemption":false,"start_date":"2024-09-04","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06453928","publication_url":"https://clinicaltrials.gov/study/NCT06453928","title":"Starting Technology in At Risk Type 1 Diabetes (STAR-T1D) Study","has_exemption":false,"start_date":"2024-09-05","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06377371","publication_url":"https://clinicaltrials.gov/study/NCT06377371","title":"A Pilot Study to Evaluate Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE","has_exemption":false,"start_date":"2024-09-11","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05983159","publication_url":"https://clinicaltrials.gov/study/NCT05983159","title":"A Modular Open Label, Signal Seeking, Phase II Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations (TARGET-VM)","has_exemption":false,"start_date":"2024-09-13","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Murdoch Childrens Research Institute","sponsor_slug":"murdoch-childrens-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05171894","publication_url":"https://clinicaltrials.gov/study/NCT05171894","title":"A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Sequential Group Comparison Study to Evaluate the Safety and Efficacy of Light Dose in Subjects With Port-wine Birthmarks Treated With Hemoporfin Photodynamic Therapy","has_exemption":false,"start_date":"2024-09-21","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.","sponsor_slug":"shanghai-fudan-zhangjiang-bio-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06086704","publication_url":"https://clinicaltrials.gov/study/NCT06086704","title":"Phase II Study of 18F-FFNP Breast PET/MRI in the Assessment of Early Response of Breast Cancer to Presurgical Endocrine Therapy","has_exemption":false,"start_date":"2024-09-25","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225387","publication_url":"https://clinicaltrials.gov/study/NCT07225387","title":"Safety and EfficacY of CombinatioN Belimumab and Voclosporin in the TrEatment of PRoliferative Forms of Lupus Glomerulopathy: Synergy Trial","has_exemption":false,"start_date":"2024-10-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"NephroNet, Inc.","sponsor_slug":"nephronet-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06369571","publication_url":"https://clinicaltrials.gov/study/NCT06369571","title":"Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet","has_exemption":false,"start_date":"2024-10-04","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06450392","publication_url":"https://clinicaltrials.gov/study/NCT06450392","title":"The Effect of Local and Systemic Tranexamic Acid on Edema and Ecchymosis in Orbital Surgery - a Prospective, Multicenter, Randomized, Double-blinded, Control Trial","has_exemption":false,"start_date":"2024-10-07","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06625060","publication_url":"https://clinicaltrials.gov/study/NCT06625060","title":"A Multicentre, Randomised, Double-blind, Placebo-controlled, Dose Escalation and Dose Finding Phase II Study to Evaluate the Safety and Efficacy of IPN10200 in the Prevention of Episodic or Chronic Migraine in Adults","has_exemption":false,"start_date":"2024-10-10","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Ipsen","sponsor_slug":"ipsen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06636071","publication_url":"https://clinicaltrials.gov/study/NCT06636071","title":"An Open-label Phase 3 Study of Setrusumab in Pediatric Japanese Subjects With Osteogenesis Imperfecta Type I, III, or IV","has_exemption":false,"start_date":"2024-10-25","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Ultragenyx Pharmaceutical Inc","sponsor_slug":"ultragenyx-pharmaceutical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06483789","publication_url":"https://clinicaltrials.gov/study/NCT06483789","title":"Efficacy and Safety of HB-1 for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial","has_exemption":false,"start_date":"2024-10-29","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"HB BioTech, LLC","sponsor_slug":"hb-biotech-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07102550","publication_url":"https://clinicaltrials.gov/study/NCT07102550","title":"Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue: A Prospective Non-Randomized Clinical Trial","has_exemption":false,"start_date":"2024-10-29","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Choon Hyuck David Kwon","sponsor_slug":"choon-hyuck-david-kwon","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06370000","publication_url":"https://clinicaltrials.gov/study/NCT06370000","title":"REMAIN1: Relapse Prevention With Maintenance Oral Azacitidine in Transplant Eligible Patients With Acute Myeloid Leukemia Not Proceeding to Transplant Due to Racial or Socioeconomic Disparities","has_exemption":false,"start_date":"2024-11-07","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05879146","publication_url":"https://clinicaltrials.gov/study/NCT05879146","title":"Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study","has_exemption":false,"start_date":"2024-11-26","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06480786","publication_url":"https://clinicaltrials.gov/study/NCT06480786","title":"Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy and Peripheral Arterial Disease: Mechanistic Insights From a Single-center, Randomized, Blinded, Sham-controlled Cross-over Proof-of-concept Trial","has_exemption":false,"start_date":"2024-12-18","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06741735","publication_url":"https://clinicaltrials.gov/study/NCT06741735","title":"Study of Fetal Health Outcomes: Working With a Missouri E-telehealth Platform","has_exemption":false,"start_date":"2024-12-19","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06701331","publication_url":"https://clinicaltrials.gov/study/NCT06701331","title":"A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2024-12-22","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06679465","publication_url":"https://clinicaltrials.gov/study/NCT06679465","title":"Evaluating the Impact of Single Dose Tiotropium on Allergen-induced Early Asthmatic Response","has_exemption":false,"start_date":"2025-01-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Saskatchewan","sponsor_slug":"university-of-saskatchewan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06720545","publication_url":"https://clinicaltrials.gov/study/NCT06720545","title":"Cardiometabolic Risk Effects of Short-term Cessation of Effective Neurostimulation Therapy in OSA","has_exemption":false,"start_date":"2025-01-05","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06773208","publication_url":"https://clinicaltrials.gov/study/NCT06773208","title":"A Phase 2 Study of Azacitidine and Venetoclax to Treat Acute Myeloid Leukemia Patients With Measurable Residual Disease Before an Allogeneic Stem Cell Transplant","has_exemption":false,"start_date":"2025-01-07","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06763653","publication_url":"https://clinicaltrials.gov/study/NCT06763653","title":"A Prospective, Multi-Center, Randomized, Controlled Trial to Compare the Safety and Efficacy of Ultra Low Frequency Spinal Cord Stimulation Plus Conservative Medical Management (CMM) to CMM Alone in the Treatment of Chronic Axial Low Back Pain With Prominent Nociceptive Etiology - The FULFILL Study","has_exemption":false,"start_date":"2025-01-17","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Presidio Medical, Inc","sponsor_slug":"presidio-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06721143","publication_url":"https://clinicaltrials.gov/study/NCT06721143","title":"A Double-blinded, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of AION-301 Administered by Intravenous Infusion for the Treatment of Participants With Stage 3 Chronic Kidney Disease","has_exemption":false,"start_date":"2025-01-23","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"AION Healthspan, Inc.","sponsor_slug":"aion-healthspan-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06738732","publication_url":"https://clinicaltrials.gov/study/NCT06738732","title":"Preliminary Evaluation of the Safety and Efficacy of CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in Individuals Diagnosed with Dravet Syndrome And/or Lennox-Gastaut Syndrome","has_exemption":false,"start_date":"2025-01-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Alexander Rotenberg","sponsor_slug":"alexander-rotenberg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06559098","publication_url":"https://clinicaltrials.gov/study/NCT06559098","title":"Vibrotactile Coordinated Reset (vCR) for the Treatment of Advanced Parkinson's Disease Patients Who Have Previously Received vCR Stimulation","has_exemption":false,"start_date":"2025-01-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06827210","publication_url":"https://clinicaltrials.gov/study/NCT06827210","title":"Treatment of Bulbar Urethral Strictures With Optilume Drug-Coated Balloons in an Untreated Population","has_exemption":false,"start_date":"2025-02-07","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Aalborg University Hospital","sponsor_slug":"aalborg-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06741644","publication_url":"https://clinicaltrials.gov/study/NCT06741644","title":"A Phase I/II, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activities of CS2009, a Tri-specific Antibody Targeting PD-1/VEGFA/CTLA-4, as Monotherapy and Combination Therapy in Participants With Advanced Solid Tumors","has_exemption":false,"start_date":"2025-02-24","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"CStone Pharmaceuticals","sponsor_slug":"cstone-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06369155","publication_url":"https://clinicaltrials.gov/study/NCT06369155","title":"A Biomarker Study of the Wee1 Inhibitor Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma","has_exemption":false,"start_date":"2025-03-05","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Joyce Liu, MD","sponsor_slug":"joyce-liu-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06806033","publication_url":"https://clinicaltrials.gov/study/NCT06806033","title":"A Phase II, Open-Label, Multicenter Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Patients With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2025-03-05","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06744465","publication_url":"https://clinicaltrials.gov/study/NCT06744465","title":"NearWave Optical Molecular Monitoring for Predicting Complete Pathological Response (pCR) to Neoadjuvant Chemotherapy (NAC) in Breast Cancer Patients","has_exemption":false,"start_date":"2025-03-07","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06852950","publication_url":"https://clinicaltrials.gov/study/NCT06852950","title":"Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge","has_exemption":false,"start_date":"2025-03-09","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06938854","publication_url":"https://clinicaltrials.gov/study/NCT06938854","title":"Prospective, Multi-center, Single-arm Investigational Study of SWM-831 to Treat Moderate and Severely Calcified Femoropopliteal Arteries","has_exemption":false,"start_date":"2025-03-10","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Shockwave Medical, Inc.","sponsor_slug":"shockwave-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06624839","publication_url":"https://clinicaltrials.gov/study/NCT06624839","title":"A PRe-pOsT Interventional Study Evaluating Gardasil Nine-valent Human Papilloma Virus (HPV) Vaccine Humoral and Cellular Immune Responses in People With or Without HIV","has_exemption":false,"start_date":"2025-03-15","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06922110","publication_url":"https://clinicaltrials.gov/study/NCT06922110","title":"A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of Azetukalner in Major Depressive Disorder","has_exemption":false,"start_date":"2025-03-18","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Xenon Pharmaceuticals Inc.","sponsor_slug":"xenon-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06760156","publication_url":"https://clinicaltrials.gov/study/NCT06760156","title":"Phase 2 Study of Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lymphoma After Axicabtagene Ciloleucel","has_exemption":false,"start_date":"2025-03-19","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06827613","publication_url":"https://clinicaltrials.gov/study/NCT06827613","title":"A Phase 1b/2, Open-label Study to Investigate the Safety and Efficacy of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Unresectable, Locally Advanced, or Metastatic Solid Tumors (START-002)","has_exemption":false,"start_date":"2025-03-24","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Marengo Therapeutics, Inc.","sponsor_slug":"marengo-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06029491","publication_url":"https://clinicaltrials.gov/study/NCT06029491","title":"The Pivotal Study of RapidPulseTM Aspiration System as Frontline Approach for Patient With Acute Ischemic Stroke Due to Large Vessel Occlusions","has_exemption":false,"start_date":"2025-03-27","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"RapidPulse, Inc","sponsor_slug":"rapidpulse-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06649851","publication_url":"https://clinicaltrials.gov/study/NCT06649851","title":"A Phase 2 Randomized Open-Label Pilot Study of Granulocyte Colony Stimulating Factor (G-CSF) to Preserve Brain Structure and Function Following Standard Chemoradiation in Patients With Newly Diagnosed MGMT-Methylated Glioblastoma","has_exemption":false,"start_date":"2025-04-02","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05968703","publication_url":"https://clinicaltrials.gov/study/NCT05968703","title":"Neurostimulation of the Nucleus Basalis of Meynert for the Cognitive-Motor Syndrome in Parkinson's Disease","has_exemption":false,"start_date":"2025-04-08","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Helen M. Bronte-Stewart","sponsor_slug":"helen-m-bronte-stewart","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06873035","publication_url":"https://clinicaltrials.gov/study/NCT06873035","title":"A Phase 2/3, Multicenter, Open-Label Phase Followed by a Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Infigratinib in Children With Hypochondroplasia: ACCEL 2/3","has_exemption":false,"start_date":"2025-04-22","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"QED Therapeutics, a BridgeBio company","sponsor_slug":"qed-therapeutics-a-bridgebio-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06867185","publication_url":"https://clinicaltrials.gov/study/NCT06867185","title":"Function And Speed of Transection Recovery After Therapeutic Electrostimulation of Nerves","has_exemption":false,"start_date":"2025-04-24","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Checkpoint Surgical Inc.","sponsor_slug":"checkpoint-surgical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06894784","publication_url":"https://clinicaltrials.gov/study/NCT06894784","title":"Semaglutide And Empagliflozin Combination Therapy Added To Automated Insulin Delivery In Adults With Type 1 Diabetes (SEMPA)","has_exemption":false,"start_date":"2025-04-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","sponsor_slug":"mcgill-university-health-centreresearch-institute-of-the-mcgill-university-health-centre","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06800404","publication_url":"https://clinicaltrials.gov/study/NCT06800404","title":"\"A Phase 2, Open Label, Efficacy and Safety Study of Autologous HB-adMSCs for the Treatment of Patients With Multiple Sclerosis\"","has_exemption":false,"start_date":"2025-05-02","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Hope Biosciences Research Foundation","sponsor_slug":"hope-biosciences-research-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06820164","publication_url":"https://clinicaltrials.gov/study/NCT06820164","title":"Lipomas Treated With Subcutaneous Injections of Cooled or Warmed Sodium Chloride: an Exploratory Study","has_exemption":false,"start_date":"2025-05-08","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06769997","publication_url":"https://clinicaltrials.gov/study/NCT06769997","title":"The Optizum Study: A Randomized, Blinded Single Center Study Evaluating the Optilume BPH Catheter System and the Rezum Water Vapor Therapy for the Treatment of Benign Prostatic Hyperplasia","has_exemption":false,"start_date":"2025-05-09","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Centre hospitalier de l'Université de Montréal (CHUM)","sponsor_slug":"centre-hospitalier-de-luniversite-de-montreal-chum","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06822426","publication_url":"https://clinicaltrials.gov/study/NCT06822426","title":"A Phase 3, Prospective, Multicenter, Double-Blind, Randomized, Controlled, Adaptive Study To Demonstrate The Safety And Efficacy Of DEFENCATH® In Reducing Central Line-Associated Bloodstream Infections (CLABSIs) In Adult Participants Receiving Total Parenteral Nutrition (TPN) Via Central Venous Catheter (CVC)","has_exemption":false,"start_date":"2025-05-14","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"CorMedix","sponsor_slug":"cormedix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06611501","publication_url":"https://clinicaltrials.gov/study/NCT06611501","title":"Glycemic Regulation as Endometriosis Adjunct Treatment","has_exemption":false,"start_date":"2025-05-22","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06672978","publication_url":"https://clinicaltrials.gov/study/NCT06672978","title":"A Multi-Center, Open-Label, Single-Arm, Phase 2 Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Vabomere (Meropenem-Vaborbactam) In The Treatment Of Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis","has_exemption":false,"start_date":"2025-06-03","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)","sponsor_slug":"rempex-a-wholly-owned-subsidiary-of-melinta-therapeutics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06953479","publication_url":"https://clinicaltrials.gov/study/NCT06953479","title":"MINMON-J: An Effectiveness Implementation Pilot Study Evaluating a Low-barrier Hepatitis C Treatment Model in a Jail Setting","has_exemption":false,"start_date":"2025-06-11","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Lifespan","sponsor_slug":"lifespan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06773026","publication_url":"https://clinicaltrials.gov/study/NCT06773026","title":"A Phase 2, Open-label, Fixed-dose Study to Assess the Efficacy of Sodium Phenylbutyrate (ACER-001) in Treating Pediatric and Adult Patients With Medium Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency Resulting From the Prevalent ACADM c.985 A>G (K304E) Mutation","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Jerry Vockley, MD, PhD","sponsor_slug":"jerry-vockley-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06886321","publication_url":"https://clinicaltrials.gov/study/NCT06886321","title":"Evaluation of the Effectiveness of Irreversible Electroporation for the Treatment of Prostate Cancer","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Chinese University of Hong Kong","sponsor_slug":"chinese-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06706232","publication_url":"https://clinicaltrials.gov/study/NCT06706232","title":"Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality","has_exemption":false,"start_date":"2025-07-07","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07105111","publication_url":"https://clinicaltrials.gov/study/NCT07105111","title":"A Phase 4, Open-Label Study to Evaluate the Efficacy of Valbenazine on Clinician- and Patient-Reported Outcomes in Patients With Tardive Dyskinesia (TD) Who Remain Symptomatic While on Deutetrabenazine or After Discontinuing Prior TD Treatment With a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor","has_exemption":false,"start_date":"2025-08-29","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Neurocrine Biosciences","sponsor_slug":"neurocrine-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06925295","publication_url":"https://clinicaltrials.gov/study/NCT06925295","title":"Image-Based Functionally Adapted Radiation Therapy for Lung Cancer","has_exemption":false,"start_date":"2025-08-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Sean Fain","sponsor_slug":"sean-fain","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06982027","publication_url":"https://clinicaltrials.gov/study/NCT06982027","title":"Assessment of Peripheral Regional Anesthetic Blockade Using a Non-Invasive Surface Electromyogram (EMG) on the Affected and Unaffected Extremity","has_exemption":false,"start_date":"2025-09-03","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06975423","publication_url":"https://clinicaltrials.gov/study/NCT06975423","title":"Somatosensory Feedback to Improve Neural Control of Walking in Older Adults","has_exemption":false,"start_date":"2025-09-08","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06052254","publication_url":"https://clinicaltrials.gov/study/NCT06052254","title":"A Double-Blind, Placebo-Controlled Evaluation of the Dexmedetomidine Transdermal Systems for Agitation Associated With Dementia of the Alzheimer's Type","has_exemption":false,"start_date":"2025-09-16","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Teikoku Pharma USA, Inc.","sponsor_slug":"teikoku-pharma-usa-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06789406","publication_url":"https://clinicaltrials.gov/study/NCT06789406","title":"Post-Market Clinical Follow-up Study of the Rechargeable Axonics SNM System Model 5101 (R20) for the Indication of Overactive Bladder (OAB)","has_exemption":false,"start_date":"2025-09-18","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Axonics, Inc.","sponsor_slug":"axonics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07159763","publication_url":"https://clinicaltrials.gov/study/NCT07159763","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CD388, a Novel Long-Acting Antiviral Conjugate, for the Prevention of Influenza in Adults and Adolescents at Higher Risk of Developing Influenza Complications","has_exemption":false,"start_date":"2025-09-25","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","sponsor_slug":"cidara-therapeutics-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07011576","publication_url":"https://clinicaltrials.gov/study/NCT07011576","title":"A Phase II Study Investigating Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC)","has_exemption":false,"start_date":"2025-09-29","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"SCRI Development Innovations, LLC","sponsor_slug":"scri-development-innovations-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07161999","publication_url":"https://clinicaltrials.gov/study/NCT07161999","title":"Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, 24-Week Study With Additional 24-Week Blinded Active Extension to Evaluate the Safety and Efficacy of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)","has_exemption":false,"start_date":"2025-10-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Coya Therapeutics","sponsor_slug":"coya-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07210463","publication_url":"https://clinicaltrials.gov/study/NCT07210463","title":"A Phase 3, Randomized, Parallel-group, Double-blind, Multicenter Study Investigating the Safety and Efficacy of NT 201 Compared With Placebo in Adult Participants With Moderate to Severe Platysma Prominence in Europe","has_exemption":false,"start_date":"2025-10-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Merz Aesthetics GmbH","sponsor_slug":"merz-aesthetics-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07215000","publication_url":"https://clinicaltrials.gov/study/NCT07215000","title":"Cleansing Options in Outpatient Setting to Improve Tolerance (COOP SIT) Trial","has_exemption":false,"start_date":"2025-10-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Morehouse School of Medicine","sponsor_slug":"morehouse-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06300528","publication_url":"https://clinicaltrials.gov/study/NCT06300528","title":"PERFORM: A Phase II Study of Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas","has_exemption":false,"start_date":"2025-10-03","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07174856","publication_url":"https://clinicaltrials.gov/study/NCT07174856","title":"The Misoprostol-Only Regimen Evidence (MORE) Study: A Randomized Controlled Trial Comparing the Misoprostol-only Regimen Versus the Combined Mifepristone and Misoprostol Regimen for Medication Abortion","has_exemption":false,"start_date":"2025-10-10","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Ibis Reproductive Health","sponsor_slug":"ibis-reproductive-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07129421","publication_url":"https://clinicaltrials.gov/study/NCT07129421","title":"A Prospective, Randomized, Multicenter Evaluation of the Safety and Effectiveness of the EMBLOK™ Embolic Protection System Compared With No Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement","has_exemption":false,"start_date":"2025-10-21","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Emblok, Inc.","sponsor_slug":"emblok-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214337","publication_url":"https://clinicaltrials.gov/study/NCT07214337","title":"Feasibility, Adoption and Efficacy of Digital Inhaler in the Management of Obstructive Lung Disease","has_exemption":false,"start_date":"2025-11-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06567717","publication_url":"https://clinicaltrials.gov/study/NCT06567717","title":"Feasibility of a Decentralized Double-Blind Randomized Controlled Trial of Zinc and Nicotinamide Riboside for the Treatment of Idiopathic Pulmonary Fibrosis","has_exemption":false,"start_date":"2025-11-03","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07121972","publication_url":"https://clinicaltrials.gov/study/NCT07121972","title":"Mirai-MRI: Multi-site Prospective Validation of AI Models for Breast Cancer Risk","has_exemption":false,"start_date":"2025-11-03","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07074886","publication_url":"https://clinicaltrials.gov/study/NCT07074886","title":"A Phase II, Randomized, Open-label, Parallel Group, Multicenter Study to Assess Bioequivalence of Two Subcutaneous Formulations of Ocrelizumab in Patients With Multiple Sclerosis","has_exemption":false,"start_date":"2025-11-13","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06827860","publication_url":"https://clinicaltrials.gov/study/NCT06827860","title":"A Phase 2 Single-Arm Study of Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse","has_exemption":false,"start_date":"2025-11-18","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Larysa Sanchez","sponsor_slug":"larysa-sanchez","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07144345","publication_url":"https://clinicaltrials.gov/study/NCT07144345","title":"Randomized, Multi-Center, Evaluator-Blind, Vehicle-Controlled Study to Evaluate Efficacy and Safety of Reformulated Levulan Kerastick Plus Photodynamic Therapy (PDT) for Field-Directed Treatment in Patients With Actinic Keratosis (AK) of Face and (Bald) Scalp","has_exemption":false,"start_date":"2025-11-19","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Sun Pharmaceutical Industries, Inc.","sponsor_slug":"sun-pharmaceutical-industries-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216976","publication_url":"https://clinicaltrials.gov/study/NCT07216976","title":"Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study","has_exemption":false,"start_date":"2025-11-19","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"MedtronicNeuro","sponsor_slug":"medtronicneuro","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07144852","publication_url":"https://clinicaltrials.gov/study/NCT07144852","title":"Randomized, Multi-Center, Evaluator-Blind, Vehicle-Controlled Study to Evaluate Efficacy and Safety of Reformulated Levulan Kerastick Plus Photodynamic Therapy (PDT) for Field-Directed Treatment in Patients With Actinic Keratosis (AK) of Upper Extremities","has_exemption":false,"start_date":"2025-11-29","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Sun Pharmaceutical Industries, Inc.","sponsor_slug":"sun-pharmaceutical-industries-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284654","publication_url":"https://clinicaltrials.gov/study/NCT07284654","title":"A Phase 3, Randomized, Double-Blind, Active-Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Subjects 50 Years of Age and Older With Immunobridging to Subjects 18-49 Years of Age","has_exemption":false,"start_date":"2025-12-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Vaxcyte, Inc.","sponsor_slug":"vaxcyte-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07205900","publication_url":"https://clinicaltrials.gov/study/NCT07205900","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Obese or Overweight Subjects Without Diabetes Mellitus","has_exemption":false,"start_date":"2025-12-02","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Hanmi Pharmaceutical Company Limited","sponsor_slug":"hanmi-pharmaceutical-company-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07283861","publication_url":"https://clinicaltrials.gov/study/NCT07283861","title":"A Phase 2 Trial of Accessory Nerve Wrapping With the Axoguard HA Plus Nerve Protector to Reduce Post-operative Neck and Shoulder Dysfunction in Patients Undergoing Neck Dissection","has_exemption":false,"start_date":"2025-12-09","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Matthew Spector","sponsor_slug":"matthew-spector","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07323784","publication_url":"https://clinicaltrials.gov/study/NCT07323784","title":"A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Efficacy of NTX-1472, a V1a Receptor Antagonist, in Adults With Social Anxiety Disorder","has_exemption":false,"start_date":"2025-12-09","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Newleos Therapeutics, Inc.","sponsor_slug":"newleos-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07250828","publication_url":"https://clinicaltrials.gov/study/NCT07250828","title":"Therapeutic Efficacy and Feasibility Study of Abbott's BurstDR Spinal Cord Stimulators Technology for Painful Diabetic Neuropathy (PDN)","has_exemption":false,"start_date":"2025-12-15","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"TriCity Research Center","sponsor_slug":"tricity-research-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06972875","publication_url":"https://clinicaltrials.gov/study/NCT06972875","title":"Efficacy and Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms Associated With Androgen-Deprivation Therapy in Men With Prostate Cancer (FLASH): A Phase 2 Study","has_exemption":false,"start_date":"2025-12-18","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Vermont","sponsor_slug":"university-of-vermont","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07294144","publication_url":"https://clinicaltrials.gov/study/NCT07294144","title":"A Study to Evaluate the Biological Effect of Tofersen in Adults With Amyotrophic Lateral Sclerosis Without Mutations in SOD1","has_exemption":false,"start_date":"2025-12-29","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07130994","publication_url":"https://clinicaltrials.gov/study/NCT07130994","title":"Reduction or Elimination of Mitral Regurgitation With the SATURN Trans-septal TMVR System in Patients With Severe, Symptomatic Mitral Regurgitation (Cassini-US)","has_exemption":false,"start_date":"2025-12-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"InnovHeart","sponsor_slug":"innovheart","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07032649","publication_url":"https://clinicaltrials.gov/study/NCT07032649","title":"Double-Blind, Placebo-Controlled Clinical Trial Evaluating Benzoyl Peroxide for Preventing Recurrence of HSV-1 Outbreaks With Rescue Crossover Option","has_exemption":false,"start_date":"2026-01-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Greg Bew","sponsor_slug":"greg-bew","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07081542","publication_url":"https://clinicaltrials.gov/study/NCT07081542","title":"Comparative Analysis of Hearing Outcomes: Robotic vs. Manual Insertion of Cochlear Implants","has_exemption":false,"start_date":"2026-01-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"AdventHealth","sponsor_slug":"adventhealth","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06646653","publication_url":"https://clinicaltrials.gov/study/NCT06646653","title":"Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the Alma System in Treating Abnormal Postpartum utErine Bleeding or Hemorrhage","has_exemption":false,"start_date":"2026-01-11","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"ResQ Medical Ltd","sponsor_slug":"resq-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07104812","publication_url":"https://clinicaltrials.gov/study/NCT07104812","title":"Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)","has_exemption":false,"start_date":"2026-01-14","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07336251","publication_url":"https://clinicaltrials.gov/study/NCT07336251","title":"Transcranial Magnetic Stimulation in Veterans With PTSD: A Pilot Study to Examine Mechanism of Effect","has_exemption":false,"start_date":"2026-01-15","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"White River Junction Veterans Affairs Medical Center","sponsor_slug":"white-river-junction-veterans-affairs-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07505004","publication_url":"https://clinicaltrials.gov/study/NCT07505004","title":"A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures","has_exemption":false,"start_date":"2026-01-29","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Praxis Precision Medicines","sponsor_slug":"praxis-precision-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07172659","publication_url":"https://clinicaltrials.gov/study/NCT07172659","title":"A 12-week, Open-label, Randomized, Standard of Care Controlled, Dose-ranging Safety and Efficacy Study of Dovramilast in People With Moderate to Severe Acute or Recurrent Leprosy Type 2 Reaction","has_exemption":false,"start_date":"2026-01-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Medicines Development for Global Health","sponsor_slug":"medicines-development-for-global-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07286201","publication_url":"https://clinicaltrials.gov/study/NCT07286201","title":"A Multicenter, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of a Bioresorbable Nasal Dressing Containing Mometasone Furoate Compared to a Steroid-eluting Sinus Stent","has_exemption":false,"start_date":"2026-01-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Polyganics BV","sponsor_slug":"polyganics-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06948045","publication_url":"https://clinicaltrials.gov/study/NCT06948045","title":"Restructuring the Mandibular Angle in Facial Aging: a Novel Tecnique Using Poly-L-Lactic Acid","has_exemption":false,"start_date":"2026-02-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Doris Hexsel","sponsor_slug":"doris-hexsel","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07304050","publication_url":"https://clinicaltrials.gov/study/NCT07304050","title":"Pilot Randomized Controlled Trial of PICTURE-Pediatric","has_exemption":false,"start_date":"2026-02-09","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07401134","publication_url":"https://clinicaltrials.gov/study/NCT07401134","title":"Improving Postoperative Recovery: A Randomized Study of Multimodal Perineal Analgesia Protocol (MPAP) After Vaginal Surgery","has_exemption":false,"start_date":"2026-02-18","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06629077","publication_url":"https://clinicaltrials.gov/study/NCT06629077","title":"Cerebrovascular Responses to Acute Hypoperfusion","has_exemption":false,"start_date":"2026-02-26","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06675357","publication_url":"https://clinicaltrials.gov/study/NCT06675357","title":"Novel FAP-targeted Approach to Imaging Patients With or High-risk for Metastatic Prostate Cancer","has_exemption":false,"start_date":"2026-02-27","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07396818","publication_url":"https://clinicaltrials.gov/study/NCT07396818","title":"A Trial of Kamlanoflast In Patients With Amyotrophic Lateral Sclerosis","has_exemption":false,"start_date":"2026-02-28","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Inflammasome Therapeutics","sponsor_slug":"inflammasome-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07523685","publication_url":"https://clinicaltrials.gov/study/NCT07523685","title":"Non-invasive Vagus Nerve Stimulation (nVNS) for Adjunctive Treatment of Symptoms Associated With Post-Traumatic Stress Disorder (PTSD)","has_exemption":false,"start_date":"2026-03-02","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Acacia Clinics","sponsor_slug":"acacia-clinics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06775964","publication_url":"https://clinicaltrials.gov/study/NCT06775964","title":"Mesenchymal Stem Cell Therapy for Early Alzheimer's Disease","has_exemption":false,"start_date":"2026-03-11","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Paul E Schulz","sponsor_slug":"paul-e-schulz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06498648","publication_url":"https://clinicaltrials.gov/study/NCT06498648","title":"Phase I/II Study to Evaluate the Feasibility and Efficacy of Sequential Abemaciclib and Gemcitabine Treatment in Patients With Retinoblastoma (Rb)+ Sarcomas","has_exemption":false,"start_date":"2026-03-18","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07538583","publication_url":"https://clinicaltrials.gov/study/NCT07538583","title":"A Multicenter, Open-label Study of QRX003 Lotion in Participants With Netherton Syndrome","has_exemption":false,"start_date":"2026-03-19","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Quoin Pharmaceuticals","sponsor_slug":"quoin-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07272161","publication_url":"https://clinicaltrials.gov/study/NCT07272161","title":"Pilot Evaluation of the StarGuide Next Generation SPECT/CT System","has_exemption":false,"start_date":"2026-03-25","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05806385","publication_url":"https://clinicaltrials.gov/study/NCT05806385","title":"Local Therapy Optimization by Grouping Immune-modulation With Cryoablation (LOGIC) for High Risk Breast Cancers","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Texas Tech University Health Sciences Center","sponsor_slug":"texas-tech-university-health-sciences-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07166198","publication_url":"https://clinicaltrials.gov/study/NCT07166198","title":"Mitigating Neural Hypoexcitability and Weakness During Disuse in Women","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Kansas State University","sponsor_slug":"kansas-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07325266","publication_url":"https://clinicaltrials.gov/study/NCT07325266","title":"Human Laboratory Study of Apremilast for Alcohol Use Disorder","has_exemption":false,"start_date":"2026-04-03","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","sponsor_slug":"national-institute-on-alcohol-abuse-and-alcoholism-niaaa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07174349","publication_url":"https://clinicaltrials.gov/study/NCT07174349","title":"The Use of an Uroselective Alpha-1-antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery","has_exemption":false,"start_date":"2026-04-10","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06496477","publication_url":"https://clinicaltrials.gov/study/NCT06496477","title":"Light Therapy to Treat Depression in Pediatric Stem Cell Therapy Recipients","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216573","publication_url":"https://clinicaltrials.gov/study/NCT07216573","title":"Continuous Blood Pressure Monitoring During Outpatient Surgery","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07349797","publication_url":"https://clinicaltrials.gov/study/NCT07349797","title":"An Open Label, Single-Center, Safety and Pharmacokinetic Study of Lumitrace® Injection (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR System Using the TGFR Reusable Sensor With TGFR Disposable Ring for the Evaluation of Kidney Function in Patients With Heart Failure","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"MediBeacon","sponsor_slug":"medibeacon","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07397247","publication_url":"https://clinicaltrials.gov/study/NCT07397247","title":"Evaluating Response to Tonic Motor Activation (TOMAC) Therapy for Patients With Restless Legs Syndrome and Dopaminergic Augmentation","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Noctrix Health, Inc.","sponsor_slug":"noctrix-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07526558","publication_url":"https://clinicaltrials.gov/study/NCT07526558","title":"A Phase II Pilot Study to Assess the Safety and Tolerability of Mast Cell Treatment in Post-tick Bite Illness","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07552415","publication_url":"https://clinicaltrials.gov/study/NCT07552415","title":"Does Joint Immobilization Following Revision Total Knee Arthroplasty (rTKA) Improve Range of Motion Following Surgery?","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07300904","publication_url":"https://clinicaltrials.gov/study/NCT07300904","title":"A Randomized, Controlled, Blinded, Prospective, Multi-center Study Evaluating Tensi+ With Transcutaneous Tibial Nerve Stimulation for the Treatment of Overactive Bladder Syndrome","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Stimuli Technology","sponsor_slug":"stimuli-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07335614","publication_url":"https://clinicaltrials.gov/study/NCT07335614","title":"An Open Label, Single Center Study to Evaluate the Effect of Protein Loading on the Measurement of Renal Reserve Using the MediBeacon® Transdermal GFR System","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"MediBeacon","sponsor_slug":"medibeacon","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07387354","publication_url":"https://clinicaltrials.gov/study/NCT07387354","title":"A Phase 1/2 Study of Pacritinib in Combination With Azacitidine for the Treatment of IPSS-M Moderate Low to Very High Risk Myelodysplastic Syndrome","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07510074","publication_url":"https://clinicaltrials.gov/study/NCT07510074","title":"MINT: Modulating Inflammation in Neuro-Trauma","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07246629","publication_url":"https://clinicaltrials.gov/study/NCT07246629","title":"Prophylactic Use of Intrathecal Calcium Channel Antagonist Through Lumbar Drain in Patients With Subarachnoid Hemorrhage Due to Aneurysmal Rupture","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07548489","publication_url":"https://clinicaltrials.gov/study/NCT07548489","title":"Phenobarbital for Agitated Delirium","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06909123","publication_url":"https://clinicaltrials.gov/study/NCT06909123","title":"A Reduced Dose of Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07460583","publication_url":"https://clinicaltrials.gov/study/NCT07460583","title":"ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes","has_exemption":false,"start_date":"2026-08-28","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05602142","publication_url":"https://clinicaltrials.gov/study/NCT05602142","title":"A Phase 1/2 Study of [11C]CPPC as a Clinical PET Radioligand Biomarker of Microglial Activation in ALS","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04979312","publication_url":"https://clinicaltrials.gov/study/NCT04979312","title":"Predictive Role of Non-Invasive Glucose Assessment During Pregnancy: A Pilot Study","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07300891","publication_url":"https://clinicaltrials.gov/study/NCT07300891","title":"T Cell Inflamed Gene Expression Profiling Score-guided Anti PD-1 Therapy (Tislelizumab Monotherapy) for Refractory Solid Cancer Patients Unexposed to Immunotherapy","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"Samsung Medical Center","sponsor_slug":"samsung-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05750589","publication_url":"https://clinicaltrials.gov/study/NCT05750589","title":"Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Pain and Corneal Epitheliopathy","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-01-31","has_results":false,"results_due":false,"sponsor_name":"iRenix Medical, Inc.","sponsor_slug":"irenix-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01786265","publication_url":"https://clinicaltrials.gov/study/NCT01786265","title":"A Randomized Study of Finite Androgen Ablation vs. Finite Androgen Ablation in Combination With Abiraterone Acetate and Prednisone in Patients With Prostate Cancer Who Have PSA Progression After Prostatectomy and/or Radiotherapy","has_exemption":false,"start_date":"2013-02-05","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01794403","publication_url":"https://clinicaltrials.gov/study/NCT01794403","title":"A Randomized Study of Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer","has_exemption":false,"start_date":"2013-04-04","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02934568","publication_url":"https://clinicaltrials.gov/study/NCT02934568","title":"An Open-label, Multi-center Rollover Protocol for Patients Who Have Participated in a Novartis-sponsored Ribociclib (LEE011) Study and Are Continuing to Benefit From Ribociclib as Single Agent or in Combination With Other Investigational Treatments","has_exemption":false,"start_date":"2016-12-15","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03609216","publication_url":"https://clinicaltrials.gov/study/NCT03609216","title":"A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations","has_exemption":false,"start_date":"2018-12-10","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03286569","publication_url":"https://clinicaltrials.gov/study/NCT03286569","title":"Study the Effect of Upper Expansion Appliances on Lower Jaw Forward Projection/Growth","has_exemption":false,"start_date":"2019-04-01","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"University of Alberta","sponsor_slug":"university-of-alberta","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03739814","publication_url":"https://clinicaltrials.gov/study/NCT03739814","title":"A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Ph-Negative, CD22-Positive B-Lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults With Relapsed or Refractory Disease","has_exemption":false,"start_date":"2019-05-08","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04095364","publication_url":"https://clinicaltrials.gov/study/NCT04095364","title":"A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum","has_exemption":false,"start_date":"2019-09-20","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"NRG Oncology","sponsor_slug":"nrg-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04268498","publication_url":"https://clinicaltrials.gov/study/NCT04268498","title":"Phase 2, Open-Label Randomized Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone vs Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2020-02-11","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04210115","publication_url":"https://clinicaltrials.gov/study/NCT04210115","title":"A Randomized, Double-blind, Placebo-controlled Phase 3 Trial of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Receiving Concurrent Definitive Chemoradiotherapy (KEYNOTE 975)","has_exemption":false,"start_date":"2020-02-28","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04551430","publication_url":"https://clinicaltrials.gov/study/NCT04551430","title":"A Randomized Phase II Trial of Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma","has_exemption":false,"start_date":"2021-01-05","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04454203","publication_url":"https://clinicaltrials.gov/study/NCT04454203","title":"Femoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Ischemic Hypertension","has_exemption":false,"start_date":"2021-02-05","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04724018","publication_url":"https://clinicaltrials.gov/study/NCT04724018","title":"Combinations of Sacituzumab Govitecan Plus Enfortumab Vedotin and Pembrolizumab for Metastatic Urothelial Carcinoma: the Double Antibody Drug Conjugate (DAD) and Double Antibody Drug Conjugate With Immunotherapy (DAD-IO) Phase I/II Trial","has_exemption":false,"start_date":"2021-05-20","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04837209","publication_url":"https://clinicaltrials.gov/study/NCT04837209","title":"A Phase II Study of NirAparib, Dostarlimab and Radiotherapy in Metastatic, PD-L1 Negative or Immunotherapy-Refractory Triple-Negative Breast Cancer (NADiR)","has_exemption":false,"start_date":"2021-07-21","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05029726","publication_url":"https://clinicaltrials.gov/study/NCT05029726","title":"Randomized, Placebo-controlled Trial of Erector Spinae Plane Blocks (ESPB) for Perioperative Pain Management for Minimally Invasive (MIS) Lumbar Spine Surgery","has_exemption":false,"start_date":"2022-02-01","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"John O'Toole","sponsor_slug":"john-otoole","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05096663","publication_url":"https://clinicaltrials.gov/study/NCT05096663","title":"A Phase II/III Study of N-803 (ALT-803) Plus Pembrolizumab Versus Standard of Care in Participants With Stage IV or Recurrent Non-Small Cell Lung Cancer Previously Treated With Anti-PD-1 or Anti-PD-L1 Therapy (Lung-MAP Non-Match Sub-Study)","has_exemption":false,"start_date":"2022-03-15","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05200442","publication_url":"https://clinicaltrials.gov/study/NCT05200442","title":"A Phase 1b/2 Study of AVUTOMETINIB and Cetuximab in Participants With Advanced KRAS Mutated Colorectal Cancer","has_exemption":false,"start_date":"2022-08-22","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05580458","publication_url":"https://clinicaltrials.gov/study/NCT05580458","title":"Phase 1/2 Open-label Trial of Safety and Zoster Immunogenicity Evaluation for People With HIV With CD4 Counts Under and Above 300 and Healthy Volunteers Following Shingrix Vaccination (ZEUS)","has_exemption":false,"start_date":"2023-03-13","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05440708","publication_url":"https://clinicaltrials.gov/study/NCT05440708","title":"REVERT- Liver Cancer: A Phase 1b/2 Multicenter, Open-label Study to Evaluate the Safety and Efficacy of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma","has_exemption":false,"start_date":"2023-03-23","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Tvardi Therapeutics, Incorporated","sponsor_slug":"tvardi-therapeutics-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05169060","publication_url":"https://clinicaltrials.gov/study/NCT05169060","title":"Effects of Fish Oil ± Salsalate on the Omega-3 Index and the Circulating Lipodome of Omega-3 Polyunsaturated Fatty Acid Metabolites in Patients With Type 2 Diabetes and Diabetic Neuropathy","has_exemption":false,"start_date":"2023-06-12","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05407441","publication_url":"https://clinicaltrials.gov/study/NCT05407441","title":"TAZNI: A Phase I/II Combination Trial of Tazemetostat With Nivolumab and Ipilimumab for Children With INI1-Negative or SMARCA4-Deficient Tumors","has_exemption":false,"start_date":"2023-08-10","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Susan Chi, MD","sponsor_slug":"susan-chi-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05861050","publication_url":"https://clinicaltrials.gov/study/NCT05861050","title":"Phase 1/2 Study of the Combination of Glofitamab, Venetoclax and Lenalidomide in Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma","has_exemption":false,"start_date":"2023-08-10","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05653258","publication_url":"https://clinicaltrials.gov/study/NCT05653258","title":"Single Nuclei RNA-sequencing to Map Adipose Cellular Populations and Senescent Cells in Older Subjects","has_exemption":false,"start_date":"2023-10-17","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06226129","publication_url":"https://clinicaltrials.gov/study/NCT06226129","title":"Gadopiclenol (Elucirem): A New Gadolinium Based Contrast Agent With High Relaxivity for Increased Contrast and Improved Differentiation of Clinically Significant Prostate Cancer on Contrast Enhanced MRI: A Prospective Study.","has_exemption":false,"start_date":"2024-02-14","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06190717","publication_url":"https://clinicaltrials.gov/study/NCT06190717","title":"Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial","has_exemption":false,"start_date":"2024-02-21","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Sonavex, Inc.","sponsor_slug":"sonavex-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06429501","publication_url":"https://clinicaltrials.gov/study/NCT06429501","title":"The Impact of Perioperative Nerve Block on Opioid Use After Craniomaxillofacial Trauma Surgery: A Randomized Controlled Trial","has_exemption":false,"start_date":"2024-04-02","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06216886","publication_url":"https://clinicaltrials.gov/study/NCT06216886","title":"Randomized Controlled Trial of Intradermal Injections of OnabotulinumtoxinA vs Saline for Trigeminal Neuralgia.","has_exemption":false,"start_date":"2024-06-01","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05699603","publication_url":"https://clinicaltrials.gov/study/NCT05699603","title":"Phase IIA, Single-Arm, Open- Label, Clinical Trial of Calcipotriene Plus 5-fluorouracil Immunotherapy for Skin Cancer Prevention in Organ Transplant Recipients","has_exemption":false,"start_date":"2024-07-02","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06700109","publication_url":"https://clinicaltrials.gov/study/NCT06700109","title":"INJECTABLE COLD ENERGY THERAPY FOR THE MANAGEMENT OF CHRONIC PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE: A MULTI-CENTER, RANDOMIZED, CONTROLLED STUDY (ICE STUDY)","has_exemption":false,"start_date":"2024-11-19","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Brixton Biosciences, Inc.","sponsor_slug":"brixton-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06586320","publication_url":"https://clinicaltrials.gov/study/NCT06586320","title":"Using Mathematical Quantification of Limb and Eye Movements of Parkinson's Disease Patients As a Biomarker for Classification and Prediction of Disease State and Response to Treatment","has_exemption":false,"start_date":"2025-02-06","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Stardots AB","sponsor_slug":"stardots-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06930703","publication_url":"https://clinicaltrials.gov/study/NCT06930703","title":"Treatment of Sickle Cell Pain and Inflammation With Cannabidiol (SPICe)","has_exemption":false,"start_date":"2025-04-03","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07132307","publication_url":"https://clinicaltrials.gov/study/NCT07132307","title":"Reducing Obstructive Sleep Apnea After Hypoglossal Nerve Stimulation Through","has_exemption":false,"start_date":"2025-07-29","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05642026","publication_url":"https://clinicaltrials.gov/study/NCT05642026","title":"The Efficacy of Continuous Intercostal Nerve Blocks in the Treatment of Patients With Multiple Rib Fractures","has_exemption":false,"start_date":"2025-09-23","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Zachary Warriner","sponsor_slug":"zachary-warriner","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07277296","publication_url":"https://clinicaltrials.gov/study/NCT07277296","title":"A Multicenter, Single-arm, Pivotal Study to Evaluate the Safety and Efficacy of the SwitchGuard™ Neuroprotection System (NPS) for Providing Cerebral Embolic Protection During Carotid Artery Stenting Via the Transcarotid Artery Revascularization (TCAR) Approach When Used in Conjunction With the CGuard™ Prime 80 Carotid Stent System","has_exemption":false,"start_date":"2026-01-01","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"InspireMD","sponsor_slug":"inspiremd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07323641","publication_url":"https://clinicaltrials.gov/study/NCT07323641","title":"A Phase II Trial of Telisotuzumab Vedotin With Osimertinib for EGFR Mutated NSCLC With c-MET Overexpression That is Progressing on Osimertinib","has_exemption":false,"start_date":"2026-02-19","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07492602","publication_url":"https://clinicaltrials.gov/study/NCT07492602","title":"Comparison of Gait Metrics in Patients With Stroke, Traumatic Brain Injury, and Multiple Sclerosis Before and After Functional Electrical Stimulation","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Casa Colina Hospital and Centers for Healthcare","sponsor_slug":"casa-colina-hospital-and-centers-for-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224529","publication_url":"https://clinicaltrials.gov/study/NCT07224529","title":"Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction","has_exemption":false,"start_date":"2026-05-01","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07508059","publication_url":"https://clinicaltrials.gov/study/NCT07508059","title":"Assessing the Impact of Biofeedback on Task Performance With Swallowing Maneuvers in Healthy Young Adults Using High Resolution Pharyngeal Manometry (HRPM)","has_exemption":false,"start_date":"2026-05-01","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05626920","publication_url":"https://clinicaltrials.gov/study/NCT05626920","title":"A Cross-over Randomized Control Trial to Evaluate the Retinaldehyde Dehydrogenase Inhibitor, Disulfiram, in Improving Retinal Sensitivity in Eyes Affected by Inherited Retinal Degeneration","has_exemption":false,"start_date":"2026-05-03","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07552974","publication_url":"https://clinicaltrials.gov/study/NCT07552974","title":"Evaluation of the Effects of Isolated Cannabidiol (CBD) on Inflammation, Pain, Sleep and Quality of Life in Brazilian Jiu-Jitsu Athletes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-02-01","has_results":false,"results_due":false,"sponsor_name":"Associação Pan-Americana Multidisciplinar de Endocanabinologia","sponsor_slug":"associacao-pan-americana-multidisciplinar-de-endocanabinologia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02662907","publication_url":"https://clinicaltrials.gov/study/NCT02662907","title":"Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy","has_exemption":false,"start_date":"2016-02-01","completion_date":"2027-02-02","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02884648","publication_url":"https://clinicaltrials.gov/study/NCT02884648","title":"A Phase II Investigation of Bevacizumab for the Treatment of Second-Look Positive Epithelial Ovarian Cancer","has_exemption":false,"start_date":"2016-11-15","completion_date":"2027-02-02","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04417621","publication_url":"https://clinicaltrials.gov/study/NCT04417621","title":"A Randomized, Open-label, Multi-arm, Two-part, Phase II Study to Assess Efficacy and Safety of Multiple LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic BRAFV600 or NRAS Mutant Melanoma","has_exemption":false,"start_date":"2020-10-30","completion_date":"2027-02-02","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null}]}